A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018.

MLA

Viprey, Virginie F., et al. “A Point-Prevalence Study on Community and Inpatient Clostridioides Difficile Infections (CDI): Results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018.” Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, vol. 27, no. 26, June 2022. EBSCOhost, https://doi.org/10.2807/1560-7917.ES.2022.27.26.2100704.

APA

Viprey, V. F., Davis, G. L., Benson, A. D., Ewin, D., Spittal, W., Vernon, J. J., Rupnik, M., Banz, A., Allantaz, F., Cleuziat, P., Wilcox, M. H., & Davies, K. A. (2022). A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018. Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, 27(26). https://doi.org/10.2807/1560-7917.ES.2022.27.26.2100704

Chicago

Viprey, Virginie F, Georgina L Davis, Anthony D Benson, Duncan Ewin, William Spittal, Jon J Vernon, Maja Rupnik, et al. 2022. “A Point-Prevalence Study on Community and Inpatient Clostridioides Difficile Infections (CDI): Results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018.” Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 27 (26). doi:10.2807/1560-7917.ES.2022.27.26.2100704.